Realization of reproductive potential in patients with atypical hyperplasia and stage I endometrial cancer


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Aim To determine the most effective way of getting pregnant for patients with a history of initial stages of endometrial cancer. Materials and methods The study comprised 77 patients of reproductive age who were seeking to conceive after achieving remission or required retrieval and cryopreservation of reproductive material before starting cancer treatment. The study participants were divided into groups classified by the presence of stage I endometrial cancer (group 1, n=48) and atypical endometrial hyperplasia (group 2, n=29). Results Seventeen (35.4%) and 6 (20.7%) women in groups 1 and 2, respectively, had polycystic ovary syndrome with severe endocrine and metabolic dysfunctions. There was a lack of unified approaches to counseling and management of this category of patients, which was associated with a high recurrence rate. Procurement of reproductive material after treatment of the present disease resulted in a limited number and poor quality of oocytes/embryos. This observation implied the need for retrieval and cryopreservation of reproductive material before starting treatment. A low pregnancy rate of 21.7% per attempt was probably associated with impaired embryo implantation and endometrial receptivity following exposure to the levonorgestrel intrauterine system. Conclusion The pregnancy rate after 69IVF attempts was 21.7% (15pregnancies). The low pregnancy rate and the questions encountered during the treatment suggest the need for further studies.

Texto integral

Acesso é fechado

Sobre autores

L. Dzhanashvili

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: lana.janashvili@gmail.com
Ph.D. Student 117997 Russia, Moscow, Ac. Oparina str. 4

T. Nazarenko

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: t.nazarenko@mail.ru
Dr.Med.Sci., Professor, Head of the Institute of Reproductive Medicine 117997 Russia, Moscow, Ac. Oparina str. 4

O. Balakhontseva

Zdanovsky Clinic

Email: osbal2383@gmail.com
Ph.D. at the Professor

Y. Martirosyan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia; I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University)

Email: marti-yana@yandex.ru
Clinical Resident at the Department of Obstetrics, Gynecology, Perinatology and Reproductive Medicine of the Medical Faculty 117997 Russia, Moscow, Ac. Oparina str. 4

S. Pronin

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: s_pronin@oparina4.ru
Ph.D., Senior Researcher at the Department of Innovative Oncology and Gynecology 117997, Russia, Moscow Ac. Oparina Street 4. Tel.: 8(495)5314444

E. Kalinina

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: e_kalinina@oparina4.ru
Dr.Med.Sci., Professor, Head of B.V. Leonov Department of Assisted Technologies in Infertility 17997, Russia, Moscow Ac. Oparina Street 4

A. Biryukova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: alma21@list.ru
Ph.D., Clinical Care Supervisor at the F. Paulsen Research and Educational Center for ART with the Clinical Department 117997 Russia, Moscow, Ac. Oparina str. 4

Bibliografia

  1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России; 2018
  2. Чулкова О.В., Новикова Е.Г., Пронин С.М. Органосохраняющее и функционально щадящее лечение начального рака эндометрия. Опухоли женской репродуктивной системы. 2007; 1-2: 50-3
  3. Jadoul P., Donnez J. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil. Steril. 2003; 80(6): 1315-24. https://dx.doi.org/10.1016/s0015-0282(03)01183-x.
  4. Минздрав Российской Федерации. Клинические рекомендации. Рак тела матки. Ассоциация онкологов России, Российское общество клинической онкологии; 2018.
  5. Guillon S., Popescu N., Phelippeau J., Koskas M. A systematic review and metaanalysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. Int. J. Gynaecol. Obstet. 2019; 146(3): 277-88. https://dx.doi.org/10.1002/ijgo.12882.
  6. Rodolakis A., Biliatis I., Morice P., Reed N., Mangier M., Kesic V., Denschlag D. European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int. J. Gynecol. Cancer. 2015; 25(7): 1258-65. https://dx.doi.org/10.1097/igc.0000000000000493.
  7. Бохман Я.В. Руководство по онкогинекологии. М.: Медицина; 1989.
  8. Dumesic D.A., Lobo R.A. Cancer risk and PCOS. Steroids. 2013; 78(8): 782-5. https://dx.doi.org/10.1016/j.steroids.2013.04.004.
  9. Chae S.H., Shim S.H., Lee S.J., Lee J.Y., Kim S.N., Kang S.B. Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer. Int. J. Gynecol. Cancer. 2019; 29(1): 77-85. https:/dx.doi.org/10.1136/ijgc-2018-000036

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2020

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies